1-6 of 6
Eva Arranz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Newly acquired chromosome Abnormalities During Course of CLL: a Retrospective Collection Data From 2 Spanish Centers.

Javier Loscertales, MD, Eva Arranz, PhD, Maria-Angeles Sanz, PhD, Carmen Burgaleta, MD, PhD, Juan-José Gil-Fernández, MD, PhD, Juan Luis Steegmann, MD, PhD, Adrian Alegre, MD
Journal: Blood
Blood (2009) 114 (22): 4384.
https://doi.org/10.1182/blood.V114.22.4384.4384
Published: 2009
Journal Articles

Transforming and Tumorogenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosin-Kinase.

Álvaro Cuesta-Domínguez, Mara Ortega, Cristina Ormazabal, Matilde Santos-Roncero, Marta Galán-Díez, Juan Luis Steegmann, MD, PhD, Eva Arranz, María Ángeles Figuera, Jaqueline Sayyah, MS, Peter P. Sayeski, PhD, José Luis Vizmanos, Juan A. Bueren, Paula Rio, Elena Fernandez-Ruiz
Journal: Blood
Blood (2009) 114 (22): 4683.
https://doi.org/10.1182/blood.V114.22.4683.4683
Published: 2009
Journal Articles

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Maria del Mar Mallo, José Cervera, MD, PhD, Julie Schanz, Blanca Espinet, PhD, Esperanza Such, Elisa Luño, MD, PhD, Christian Steidl, MD, María Luisa Martín, Ulrich Germing, Javier Grau, MD, Michael Pfeilstoecker, MD, Jesús M Hernández, MD, PhD, Thomas Noesslinger, M.a José Calasanz, PhD, Peter Valent, MD, Rosa Collado, MD, PhD, Christa Fonatsch, Encarna Bureo, MD, Michael Lübbert, MD, PhD, Rafael Ríos, MD, PhD, Reinhard Stauder, MD, Eva Arranz, Barbara Hildebrandt, Marilyn L. Slovak, PhD, Juan Cigudosa, PhD, Virginie Eclache, Otto Krieger, Carmen Pedro, MD, Marta Salido, Leonor Arenillas, MD, Guillermo Sanz, MD, PhD, Miguel A. Sanz, MD, PhD, Ana Valencia, Lourdes Florensa, MD, PhD, Detlef Haase, MD, PhD, Francesc Solé, PhD
Journal: Blood
Blood (2008) 112 (11): 1649.
https://doi.org/10.1182/blood.V112.11.1649.1649
Published: 2008
Journal Articles

Idiopathic Cytopenia of Undetermined Significance (ICUS): Impact of Flow Cytometry Immunophenotyping (FCI) in the Diagnosis of Myelodysplastic Syndrome (MDS) When Morphology Is Not Conclusive.

Patricia Font, MD, Dolores Subira, PhD, Javier Loscertales, MD, Eva Arranz, PhD, Arancha Alonso, MD, M. Angeles Perez-Saenz, PhD, Antonio Escudero, PhD, Jose Maria Fernandez-Rañada, PhD, Teresa Vallespi, PhD
Journal: Blood
Blood (2007) 110 (11): 2467.
https://doi.org/10.1182/blood.V110.11.2467.2467
Published: 2007
Journal Articles

Acute Erythroid Leukemia (AEL): A Clinical, Morphological, Cytogenetic and Follow-Up Study of 69 Patients.

Elisa Luño, Carmen Sanzo, Francesc Sole, Mirian Gonzalez, Isabel Granada, Blanca Espinet, Cristina Chamorro, Rosa Collado, Ana Cabello, M. Jose Calasanz, Eva Arranz, Juan M. Bergua
Journal: Blood
Blood (2005) 106 (11): 3271.
https://doi.org/10.1182/blood.V106.11.3271.3271
Published: 2005
Journal Articles

Phenotypic Aberrations of Myeloid CD34+ Cells in Patients with Myelodysplastic Syndrome (MDS): Clinical Significance and Correlation with Cytogenetics Abnormalities.

Dolores Subira, MD, PhD, Patricia Font, MD, Eva Arranz, MD, PhD, Ramiro B Soraya, Susana Castanon, TcH, Mónica Renedo, MD, PhD, Carlos Blas, MD, Maria F. Garcia B, Olga Gonzalez B, José F. Tomas, MD, PhD, José M. Fernandez-Rañada, MD
Journal: Blood
Blood (2004) 104 (11): 2374.
https://doi.org/10.1182/blood.V104.11.2374.2374
Published: 2004